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Cln3 cyclin of the budding yeast Saccharomyces cerevisiae is a key regulator of Start, a cell cycle event in G1
phase at which cells become committed to division. The time of Start is sensitive to Cln3 levels, which in turn
depend on the balance between synthesis and rapid degradation. Here we report that the breakdown of Cln3
is ubiquitin dependent and involves the ubiquitin-conjugating enzyme Cdc34 (Ubc3). The C-terminal tail of
Cln3 functions as a transferable signal for degradation. Sequences important for Cln3 degradation are spread
throughout the tail and consist largely of PEST elements, which have been previously suggested to target
certain proteins for rapid turnover. The Cln3 tail also appears to contain multiple phosphorylation sites, and
both phosphorylation and degradation of Cln3 are deﬁcient in a cdc28
ts mutant at the nonpermissive temper-
ature. A point mutation at Ser-468, which lies within a Cdc28 kinase consensus site, causes approximately
ﬁvefold stabilization of a Cln3–b-galactosidase fusion protein that contains a portion of the Cln3 tail and
strongly reduces the phosphorylation of this protein. These data indicate that the degradation of Cln3 involves
CDC28-dependent phosphorylation events.
The progress of cells through the division cycle is subject to
controls ensuring faithful duplication of genetic material and
other cell components. In the budding yeast Saccharomyces
cerevisiae, environmental signals such as nutrient status are
monitored in the central control step of the cell cycle, known as
Start (35). Cell growth and division are coordinated by regu-
lating the timing of this event. Upon the execution of Start,
cells become irreversibly committed to division. An analogous
G1 event resulting in irreversible commitment to cell division
has been described for mammalian cells and is known as the
restriction point (33). Traversal of mammalian cells through
the restriction point may involve the accumulation of unstable
G1 cyclins (6).
The timing of Start in yeast cells is controlled principally by
Cln1, Cln2, and Cln3 (31). Each of these proteins contains a
sequence motif conserved among all cyclins, which is thought
to mediate their association with the cell cycle regulatory ki-
nase Cdc28 (the cyclin box [14, 30]). Physical interaction with
and activation of Cdc28 have been documented for all three
Cln proteins (5, 48, 52). Cln3 differs dramatically from Cln1
and Cln2 in several respects. It is approximately 20- to 100-fold
lower in abundance than Cln1 and Cln2 (47) and appears to
lack the distinctly periodic expression of Cln1 and Cln2 (5, 47,
52). Nonetheless, cln3 deletion mutants have more pro-
nounced cell cycle defects than do cln1 and cln2 mutants (47).
Recent experiments suggest that the primary function of
Cln3 is to induce CLN1, CLN2, and perhaps other genes (23,
47). Thus, Cln3 appears to play a critical but indirect role in
Start. Accumulation of Cln1 and Cln2 is apparently necessary
for the subsequent expression of CLB1 to CLB4, which func-
tion in later stages of the cell cycle, particularly mitosis (1).
Thus, Cln3 may serve as the initiator of a cascade of cyclin
induction events. In controlling the initiation of this pathway,
Cln3 coordinates cell growth and division.
The transcriptional controls that regulate all other known
cyclin genes have not been observed for CLN3. However, the
Cln3 protein is highly unstable, and mutations that stabilize
Cln3 cause small cell size and precocious entry into S phase
(30, 48). The short half-life of Cln3 may allow its steady-state
abundance to be regulated rapidly and sensitively by changes in
growth rate, protein synthesis, and cell size. Thus, the instabil-
ity of Cln3 may underlie the ability of cells to adapt rapidly to
ﬂuctuating growth conditions and to avoid undergoing cell
division under adverse conditions. The instability of Cln3 and
perhaps its mammalian homologs therefore appears to be fun-
damental to their roles in coordinating cell growth and divi-
sion.
Transferable signals for degradation have been identiﬁed in
a number of short-lived proteins (12, 19, 24, 26). Here we
characterize the degradation signal in Cln3 and show that it
targets Cln3 for ubiquitin-dependent proteolysis. Ubiquitin
serves as a marker for the degradation of many proteins in
eukaryotes (8, 16, 21, 50). Cln3 apparently provides the ﬁrst
example of a signal for ubiquitin-dependent degradation com-
posed primarily of PEST sequences. Such sequences, enriched
in proline (P), glutamate (E), serine (S), and threonine (T), are
present in a variety of short-lived proteins and have been
proposed to target these proteins for turnover (37). The Cln3
degradation signal appears to be relatively complex; even a
minimal signal consists of several critical elements and may
require more than 80 amino acids. In particular, phosphoryla-
tion of the Cln3 degradation signal appears to be critical for its
recognition. On the basis of the results below, we propose that
PEST sequences involved in degradation function to couple
phosphorylation with ubiquitination. The phosphorylation
events implicated in Cln3 degradation are dependent on Cdc28
kinase, which physically associates with Cln3. Thus, Cln3 may
be negatively regulated by the same cell cycle machinery that it
activates.
MATERIALS AND METHODS
Yeast media and genetic techniques. Standard techniques were used for strain
construction, transformation, and tetrad dissection (38). Cultures were grown at
308C unless otherwise indicated. YPD medium consisted of 1% yeast extract, 2%
* Corresponding author. Mailing address: Department of Cell Biol-
ogy, Harvard Medical School, 25 Shattuck St., Boston, MA 02115.
Phone: (617) 432-3492. Fax: (617) 432-1144.
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 Bacto Peptone, and 2% glucose. Synthetic media consisted of 0.7% Difco yeast
nitrogen base supplemented with amino acids and uracil as described previously
(38) and 2% glucose. Adenine was also used as a supplement when appropriate.
For galactose induction, the same media were used except that methionine,
uracil, and glucose were omitted and 2% galactose, 2% glycerol, 2% ethanol, and
40 mg of aspartate per ml, or alternatively 3% galactose and 2% rafﬁnose, were
added, as indicated.
Yeast strains. Unless otherwise indicated, experiments were carried out with
the previously described (9) strain SUB62 (MATa ura3-52 leu2-3,112 lys2-801
his3-D200 trp1-1[am]), which also served as the congenic control strain in exper-
iments involving ubiquitin-conjugating (Ubc) enzyme mutants (with the excep-
tion of the ubc8 mutants [36]). cdc34-1 (KY201), cdc34-2 (KY203), and congenic
control (KY130; MATa bas1-2 bas2-2 ura3-52 leu2-D1 gcn4-D ade8::GCN4)
strains were supplied by D. Kornitzer. The cdc28-4 strain (FC10-29) and con-
genic control (FC12-18; MATa bar1 trp1 leu2 ura3 his2 ade1) were supplied by F.
Cross. The pre1-1 pre1-4 mutant (yHI29/14) and congenic control (yHI29/W;
MATa ura3 leu2 his3) strains were from D. Wolf.
Construction of deletions in the chromosomal CLN3 gene. Standard tech-
niques were used for manipulation and sequencing of DNA (40). A linker with
appropriate restriction sites and termination codons in each reading frame was
cloned into a derivative of plasmid pBF30 (30) immediately before the CLN3
stop codon to yield an open reading frame ending in the sequence CGCAGCG
GCCGCAGATCTCGAGGTACCGTCGACTGATTAATTAGCGCCGCTGA
(plasmid pBF1) (bases in boldface type are derived from wild-type CLN3).
Exonuclease III was used to generate nested unidirectional deletions (40) within
the linker. Mutants were characterized by restriction mapping and sequencing
(see Fig. 3). For selected mutants, a triple hemagglutinin (HA) epitope (7, 47,
48) was then cloned into a NotI site that had been placed in the SalI site of the
original linker. The genomic CLN3 gene of strain W303a (MATa ura3 leu2 his3
trp1 ade2 can1) was then replaced with a mutant cln3 gene in two steps. First, the
1.4-kbp XhoI-to-HpaI fragment at the CLN3 locus was replaced with the LEU2
gene by homologous recombination. The LEU2 marker was then replaced by a
PvuII fragment of one of the mutant versions of pBF1, thus transferring a
truncated version of CLN3 to the chromosome. The PvuII fragment carries a
URA3 marker upstream of CLN3 (30). For measurement of protein half-lives, a
LEU2-GAL1 fragment was then inserted in place on the wild-type promoter by
homologous recombination.
Construction of Cln3–b-Gal plasmids. All Cln3–b-galactosidase (b-Gal) con-
structions, including those of deletion variants, involved cloning PCR fragments
into the BamHI site of pLGSD5 (2). The Cln3 sequence is thus inserted near the
N terminus of the 45-residue LacI-derived sequence which is joined to b-Gal (2).
The Cln3M-expressing plasmid described in reference 48 was used as the tem-
plate for all PCR experiments. 59 endpoints of CLN3 derived inserts extending to
codon 404 correspond to the synthetic BamHI site of this plasmid.
Construction of plasmids expressing Cln3-HA from the CUP1 promoter. The
Cln3M-expressing plasmid (48) was used as template for PCR of the entire
1.7-kbp CLN3 open reading frame. Cln3M, which is identical to Cln3-HA used
in this work, carries a triplicated HA tag inserted between residues 403 and 404
of Cln3. The sense oligonucleotide carried an EcoRI site 59 to the ATG, and the
antisense oligonucleotide carried a KpnI site 39 to the stop codon. The 1.7-kbp
PCR fragment was digested with EcoRI and HindIII (at the natural HindIII site
of Cln3), producing a 700-bp 59 fragment. A 1-kbp 39 fragment was produced by
digestion with HindIII and KpnI. From the TRP1-marked vector Yep96 (10), we
prepared a 5.5-kbp BamHI-KpnI fragment and a 430-bp BamHI-EcoRI frag-
ment. These four fragments were ligated to produce plasmid Ye17, which ex-
presses Cln3 from the CUP1 promoter. The sequence of the entire CLN3-HA
open reading frame was conﬁrmed by sequencing. For transformation into Trp
1
strains, the 2.1-kbp BamHI-KpnI fragment from Ye17 was subcloned into the
LEU2-marked vector YEplac181 (11).
Measurement of Cln3 half-life by immunoblotting. Measurement of Cln3
half-life has been described previously (48). Brieﬂy, cells containing GAL-CLN3
constructs were grown in YEP-galactose (1% yeast extract, 2% Bacto Peptone,
2% galactose) for 24 h to a density of 0.5 3 10
7 cells per ml. Glucose was added
to 2% to repress the GAL promoter, and samples were taken at intervals.
Northern (RNA) analysis was used to conﬁrm that CLN3 mRNAs for all mutants
had disappeared within 7 min of glucose addition. Equal loading of total pro-
tein in each lane was conﬁrmed by using anti-b-tubulin antibody (a gift of F.
Solomon). Reaction of monoclonal antibody 12CAS with the triple HA epitope
was visualized by an enhanced chemiluminescence system (Amersham). Multiple
exposures were used to ﬁnd the range within which the response of the ﬁlm was
linear. Exposures within the linear range were scanned with a Molecular Dy-
namics densitometer, and the half-life and relative abundance were determined
for each protein.
Measurement of Cln3-HA and Cln3–b-Gal half-life by pulse-chase analysis.
Pulse-chase procedures, cell lysis, immunoprecipitations, and gel electrophoresis
were carried out essentially as described previously (10).
35S-amino acids
(Tran
35S-label) were from ICN. The addition of a variety of phosphatase inhib-
itors to the immunoprecipitation buffer was found to have no effect on the
recovery of phosphorylated Cln3–b-Gal. The duration of labeling was 5 min in all
pulse-chase experiments. Cln3–b-Gal half-life measurement was carried out with
the synthetic media described above following 2 or more h of galactose induction.
For pulse-chase analysis of Cln3-HA, cells were grown in appropriately selective
synthetic media with 2% glucose in place of rafﬁnose. Exponentially growing cells
were induced with 0.1 mM CuSO4 for 6 h and pulse-labeled. In experiments
involving temperature-sensitive mutants, cells were grown at room temperature,
shifted to 378C after6hi nt h epresence of CuSO4, and pulse-labeled 30 min
later. Half-life values were determined with a Molecular Dynamics PhosphorIm-
ager as described previously (10).
32Pi labeling. Phosphate labeling was carried out with YEP depleted of Pi
(YEP-P) as described previously (51), supplemented with appropriate carbon
sources. For phosphate labeling of b-Gal derivatives, cells were grown to expo-
nential phase in synthetic medium lacking uracil and supplemented with 2%
galactose, 2% glycerol, 2% ethanol, and 40 mg of aspartate per ml. Cells were
harvested by centrifugation, washed three times with distilled H2O, and resus-
pended in YEP-P supplemented with 2% galactose, 2% glycerol, 2% ethanol,
and 40 mg of aspartate per ml. After 4 h, 0.1 to 0.3 mCi of
32Pi was added to the
medium, and incubation was continued for 40 min. Cells were then processed for
immunoprecipitation as described above.
For
32Pi labeling of Cln3-HA, cultures were grown to exponential phase in
synthetic medium lacking leucine and methionine. CuSO4 was then added to 100
mM, and incubation was resumed for 3 h. Cells were harvested and washed as
described above, then resuspended in YEP-P supplemented with 100 mM CuSO4
and 2% glucose, and incubated for an additional 2 h. The culture temperature
was then shifted to 378C; after an additional 30 min, 1.5 mCi of
32Pi was added
to each 8-ml culture, and labeling was carried out at 378C for 25 min.
RESULTS
Construction and analysis of a nested set of Cln3 deletions.
Sequences important for degradation of Cln3 were identiﬁed
by making a set of nested deletions from the 39 end of the
CLN3 open reading frame. For biochemical analysis, many of
the Cln3 deletions were tagged with the HA epitope at their C
termini. Constructs were placed under control of either the
CLN3 or GAL promoter and transplaced back into the yeast
genome, replacing the wild-type copy of CLN3.
The effects of the mutations on protein half-life were as-
sayed in two ways. First, the half-life of Cln3 overexpressed
from the GAL promoter was determined directly, by measur-
ing Cln3 abundance at different times after shutting off the
GAL promoter (Fig. 1C and 2A). Second, the steady-state
abundance of Cln3 protein expressed from either the GAL or
CLN3 promoter was determined by immunoblot analysis (Fig.
1C, 2B, and 2C). Assuming constant synthesis, the abundance
of each mutant protein should be inversely proportional to the
decay constant. The results of these two assays were in excel-
lent agreement with one another: mutations causing increased
half-life caused expected increases in steady-state protein
abundance (Fig. 1 and 2). These experiments demonstrated
that deletions throughout the Cln3 tail lead to stabilization of
the protein (see below).
To test for phenotypic effects of Cln3 stabilization, the cell
volume of each mutant was measured with a Coulter Channel-
izer (30). Cell volume is closely related to the level of Cln3
protein: as the amount of Cln3 in the cell increases, mode cell
volume decreases (4, 30, 47). Thus, mutations increasing the
stability of Cln3 protein decrease cell size. Conversely, muta-
tions decreasing the speciﬁc activity of Cln3 increase cell size.
This is an important assay because it can monitor the in vivo
activity of untagged Cln3 expressed from its own promoter.
This assay was done with both tagged and untagged versions of
each mutant gene (Fig. 3B). In general, the C-terminal tag
caused a slight increase in mode cell volume (presumably due
to a slight destabilization of Cln3).
Deletion of the Cln3 tail (amino acids 404 to 580), which
stabilized the protein, conferred a small-cell phenotype, as
previously observed (30) (Fig. 3B). Deletions that extend be-
yond the tail resulted in a large-cell phenotype, presumably
because they inactivate Cln3. For deletions within the tail, the
cell volume assay was in good agreement with measurements
of half-life and abundance of Cln3 except in the case of the
three smallest C-terminal deletions (526, 514, and 478).
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 In the exceptional mutants, cell volume increased (indicating
a decrease in CLN3 activity), despite an increase in Cln3 pro-
tein levels. In single copy, these three mutant genes were un-
able to complement a cln1 cln2 cln3 triple mutation (Fig. 1C);
a fourth mutant, 560, which lacks only the last 20 amino acids
of Cln3, conferred a large-cell-size phenotype comparable to
that of a cln3 deletion (data not shown). However, when mu-
tant genes 526, 514, and 478 were overexpressed from the
GAL1 promoter, they reduced the cell size, showing that they
had some cyclin function (data not shown). Overexpression of
these genes also resulted in complementation of the cln1 cln2
cln3 triple mutation (data not shown). These results suggest
that the last 20 amino acids of Cln3 are required for full
activity; for example, they could constitute a localization signal.
When the truncated proteins are stabilized or overexpressed,
the increased quantity of Cln3 may compensate for its lowered
speciﬁc activity. In summary, the biological activity of Cln3 can
be perturbed by deletions throughout the Cln3 tail, as a result
of effects on Cln3 stability and, in the case of the C-terminal 20
amino acids, Cln3 function.
Multiple PEST elements participate in Cln3 turnover. We
deﬁne ﬁve PEST elements in the tail of Cln3, on the basis of
the criteria of Rogers et al. (37) (Fig. 1). In general, there was
a correlation between removal of PEST regions and stabiliza-
tion of Cln3. Complete loss of the PEST-rich tail caused an
eightfold increase in protein half-life and abundance and a
25% decrease in cell volume. A 32-amino-acid deletion of
residues 490 to 522 (PEST 3 and PEST 4) increased half-life
and abundance by about twofold (Fig. 2C and data not shown)
and decreased cell size by about 8%. A nonoverlapping 34-
amino-acid deletion of residues 449 to 483 (internal to PEST
2) increased protein half-life and abundance by about fourfold
(Fig. 2C and data not shown) and decreased cell size by about
16%. However, little or no phenotype change resulted from
deletion of amino acids 441 to 456 (Fig. 3B), which encom-
passes two potential Cdc28 phosphorylation sites and removes
the N-terminal part of PEST 2. A critical portion of PEST 2
must therefore lie between amino acids 457 and 483.
Although PEST 2 is an important determinant of instability,
all ﬁve PEST elements are in domains contributing to Cln3
turnover (Fig. 1 and 2). Thus, the turnover of Cln3 is not due
to a single small signal, functioning in an all-or-none fashion.
Rather, there are multiple proteolytic signalling components
spread throughout the PEST-rich tail.
A transferable signal for degradation in the Cln3 tail. To
test whether the Cln3 tail contains a transferable degradation
signal, this segment was fused to a stable protein, Escherichia
coli b-Gal, and expressed in yeast cells (Fig. 4). The resulting
Cln3(404-580)–b-Gal hybrid protein (Cln3–b-Gal) was high-
ly unstable, being degraded with an initial half-life of ap-
proximately 15 min (see below). Using the same pulse-chase
procedure as for Cln3–b-Gal, we observed a half-life of ap-
proximately 5 min for HA-tagged Cln3 (see below); thus, deg-
radation of Cln3–b-Gal is approximately threefold slower than
that of Cln3 itself. This result suggests that the determinants of
Cln3 degradation are localized primarily, but not exclusively,
within the Cln3 tail.
We further characterized the structure of the Cln3 degrada-
tion signal by deletion analysis of Cln3–b-Gal. The N-terminal
half of the Cln3 tail (amino acids 404 to 488) conferred a
30-min half-life on b-Gal (Fig. 4; see also below). We do not
know whether the C-terminal half of the tail is also sufﬁcient to
signal degradation, because b-Gal constructs containing either
residues 489 to 580 or residues 489 to 561 of Cln3 are rapidly
cleaved to release a fragment of approximately the size of
b-Gal.
FIG. 1. Deletion mapping of sequences involved in Cln3 degradation. (A) Sequence of Cln3 from amino acids 401 to 580 (the C terminus). P, D, S, and T residues
are underlined. Five PEST regions (PEST 1 [amino acids 419 to 436], PEST 2 [amino acids 446 to 483], PEST 3 [amino acids 488 to 497], PEST 4 [amino acids 501
to 525], and PEST 5 [amino acids 562 to 574]) are indicated by heavy black bars. Asterisks indicate potential Cdc28 phosphorylation sites (SP or TP) (34); ‘‘Ser468’’
marks the sole site within the tail that satisﬁes the stringent consensus sequence (S/T-P-X-K/R) for Cdc28 phosphorylation (29, 34). Carets mark basic amino acids (H,
K, and R). (B) Schematic drawing of C-terminal truncations. The top bar shows the PEST regions and potential Cdc28 phosphorylation sites (*). The number for each
truncation mutant refers to the last Cln3 residue present. CLN3-1 is a nonsense mutation causing complete loss of the tail sequence (30) and small cell size (45). (C)
Summary of gene function, protein abundance, and protein half-life for the full-length protein and six truncation mutants expressed from the GAL promoter. ND, not
determined.
VOL. 15, 1995 DEGRADATION OF Cln3 CYCLIN 733
 
a
t
 
u
n
i
v
e
r
s
i
t
y
 
l
i
b
r
a
r
y
 
o
n
 
A
u
g
u
s
t
 
2
4
,
 
2
0
0
7
 
m
c
b
.
a
s
m
.
o
r
g
D
o
w
n
l
o
a
d
e
d
 
f
r
o
m
 Two nested sets of deletions were constructed from
Cln3(404-488)–b-Gal (Fig. 4). All of these deletions stabilized
the protein (Fig. 4). Thus, the minimal signal deﬁned by this
analysis consists of 85 residues. The size of the signal cannot be
accounted for by the existence of two small, broadly spaced
required elements, because not only terminal deletions (Cln3
[404-472]–b-Gal; Cln3[419-488]–b-Gal) but also an internal
deletion (Cln3[404-436;458-488]–b-Gal) and a separate point
mutation (Cln3[S468A]–b-Gal) caused stabilization (Fig. 4;
see also below). Whether amino acids 404 to 488 comprise the
smallest segment from the tail that can signal degradation
could be established only by a more comprehensive set of
deletions.
Deletion analysis of Cln3–b-Gal suggested the importance
of PEST elements in the Cln3 degradation signal. The 85-
residue minimal signal includes PEST 1 and 2 as well as a
16-residue segment N-terminal to PEST 1. Overall, the mini-
mal signal is composed of 59% P, S, T, D, and E. Although
PEST 2 alone is not sufﬁcient to target b-Gal for degradation,
it clearly plays a critical role within the context of Cln3(404-
488)–b-Gal, because three nonoverlapping mutations within
PEST 2 result in fourfold or greater stabilization (deletions of
amino acids 437 to 457 and 473 to 488 and substitution of S468;
Fig. 4; see also below).
When Cln3(404-488)–b-Gal was analyzed electrophoreti-
cally, two bands were observed (Fig. 4C). The retarded band
was identiﬁed as a phosphorylated form by phosphatase diges-
tion (Fig. 4D) and
32Pi-labeling experiments (Fig. 5). The N- or
C-terminal deletions that stabilized the protein also reduced
levels of phosphorylation (Fig. 4 and 6, Cln3[404-472]–b-Gal
and Cln3[419-488]–b-Gal). Interestingly, two separate regions
(404 to 436 and 457 to 488) are required for efﬁcient phos-
phorylation. Between these two regions is a segment (amino
acids 437 to 457) required for degradation but not for phos-
phorylation (Fig. 4B). The latter does not simply serve as a site
of ubiquitin attachment in the fusion protein, because degra-
dation of the fusion protein requires the well-described (50)
ubiquitination sites in b-Gal, lysines 15 and 17. This was shown
by substituting arginine residues at these positions, which re-
sulted in complete stabilization of Cln3(404-488)–b-Gal (data
not shown).
Cln3–b-Gal degradation is ubiquitin dependent. The path-
way of Cln3–b-Gal degradation was initially investigated by
using a mutant in the cytoplasmic protease known as the pro-
teasome. The essential genes PRE1 and PRE4 encode subunits
of this 20S complex (15, 18). Figure 7C shows that turnover of
Cln3(404-580)–b-Gal was strongly inhibited in a pre1-1 pre4-1
double mutant. Because the proteasome mediates degradation
of ubiquitin-protein conjugates (15, 16, 43), this result sug-
gested a role for ubiquitin in Cln3–b-Gal degradation.
Efﬁcient degradation of many proteins requires the sequen-
tial ligation of ubiquitin molecules to the substrate to form a
multiubiquitin chain linked through Lys-48 of ubiquitin (3, 8).
An arginine substitution at this position (UbK48R) prevents
chain formation and protein breakdown in vitro (3) and is
lethal in S. cerevisiae (10). However, when UbK48R was over-
FIG. 2. Half-life and abundance of mutant Cln3 proteins. (A) Immunoblot analysis showing loss of Cln3 protein and its truncated derivatives with time after shutting
off GAL-CLN3 expression. ‘‘HA’’ indicates that the form of the protein tagged with the triple HA epitope (46, 47) was used. The electrophoretically retarded bands
represent phosphorylated forms of Cln3 (data not shown; see also Fig. 8). (B) Steady-state Cln3 levels for a variety of HA-tagged mutant proteins expressed from the
GAL promoter. 13,3 3 , and 123 refer to exposure times. Serial dilutions of tagged Cln3-1 extract were used to deﬁne the range within which the response of the
enhanced chemiluminescence system was linear. GALwt(wild type)HA and GAL580HA differ by the presence of a C-terminal linker. The C-terminal sequences of these
and all other constructs shown are given in Fig. 3C. In panels A and B, all visible bands are Cln3 derived. Essentially identical results were obtained for the deletion
series with expression from the CLN3 promoter (data not shown). (C) Steady-state protein levels for wild-type Cln3, the 478 truncation, and the two internal deletion
mutant proteins, all tagged and expressed from the CLN3 promoter. The asterisk indicates a nonspeciﬁc band cross-reacting with the anti-HA antibody. ‘‘Tub2’’
indicates b-tubulin used as a loading control.
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 produced in yeast cells in the presence of wild-type ubiquitin,
only a mild stabilization of Cln3(404-580)–b-Gal was observed
(data not shown). The weakness of this effect may reﬂect re-
moval of UbK48R from multiubiquitin chains by deubiquiti-
nating enzymes and its replacement by wild-type ubiquitin
(10).
To inhibit this putative editing process, the UbK48R muta-
tion was combined with a mutation that interferes with deu-
biquitination, UbG76A (20). Glycine 76, the C-terminal resi-
due of ubiquitin, is the site of ubiquitin attachment to e-amino
groups of protein lysine residues. Conjugation of the double-
mutant ubiquitin to a nascent chain appears to inhibit both
elongation and deubiquitination and thus results in a chain of
relatively static length that is too short to signal degradation
(10). Figure 7E shows that overexpression of UbK48R,G76A
results in strong stabilization of Cln3(404-580)–b-Gal. Thus,
the breakdown of this polypeptide appears to be ubiquitin
dependent. Moreover, stabilization was accompanied by the
FIG. 4. Deletion analysis of Cln3–b-Gal. (A) Schematic representation of Cln3 showing the cyclin box and PEST elements. (B) Stability and phosphorylation of
fusion proteins in which the indicated sequences from Cln3 are joined to the N terminus of b-Gal (see Fig. 7 and 9 for quantitation of half-lives). U, unstable; S, stable.
(C) Pulse-chase experiments performed on speciﬁc derivatives of Cln3–b-Gal. Arrows indicate phosphorylated forms (see also Fig. 4D and 5 to 7 for phosphorylation
of Cln3–b-Gal derivatives). (D) Treatment of Cln3(404-488)–b-Gal with potato alkaline phosphatase (PAP). The faint bands migrating more rapidly than full-length
Cln3(404-488)–b-Gal are background bands from the immunoprecipitation. After cell lysis, the fusion proteins were immunoprecipitated with antibody to b-Gal,
analyzed electrophoretically, visualized by ﬂuorography, and quantitated. For all experiments involving Cln3–b-Gal derivatives, the reported half-life values are based
on the pooled intensities of both phosphorylated and nonphosphorylated bands. For proteins designated as stable, no signiﬁcant degradation could be detected with
a 90-min chase. For Cln3–b-Gals with intermediate levels of phosphorylation indicated, the phosphorylated band could be detected only upon ﬂuorographic
overexposure (see Fig. 6). Phosphatase treatments were performed as described previously (48). We note that expression of the same C-terminal Cln3 fragment at
the C terminus of b-Gal resulted in equivalent destabilization.
FIG. 5. The electrophoretically retarded form of Cln3(404-488)–b-Gal is
phosphorylated. Cultures expressing either Cln3(404-488)–b-Gal or b-Gal with
no Cln3-derived sequences were grown in synthetic medium and subcultured in
either
32Pi labeling medium or
35S-amino acid labeling medium. Proteins were
radiolabeled and analyzed as described in the legend to Fig. 4 and in Materials
and Methods. The ratio of
32Pt o
35S counts per minute was approximately
50-fold greater for Cln3(404-488)–b-Gal than for b-Gal. No
32Pi-labeled band
corresponding to the faster-migrating form of Cln3(404-488)–b-Gal was detect-
able. Autoradiographic overexposures showed that, in contrast, phosphorylation
of b-Gal itself was not associated with an electrophoretic mobility shift (data not
shown).
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 accumulation of a periodic array of high-molecular-weight
Cln3–b-Gal derivatives, which could be visualized upon ﬂuoro-
graphic overexposure (Fig. 7F). The spacing of these bands
and their dependence upon overexpression of a mutant ubiq-
uitin suggest that they represent progressively ubiquitinated
forms of Cln3–b-Gal. A different modiﬁed form of Cln3–b-Gal
accumulates to much higher levels upon overexpression of
UbK48R,G76A (Fig. 7E). This band was found to disappear
upon phosphatase treatment and thus represents a phosphor-
ylated form of Cln3–b-Gal (data not shown; see also below).
Involvement of Ubc enzymes in Cln3–bgal degradation. Ubc
enzymes are required for transferring ubiquitin to protein sub-
strates (21). The various Ubc enzymes that have been identi-
ﬁed in S. cerevisiae deﬁne distinct pathways of ubiquitin con-
jugation. Cln3–b-Gal was not stabilized in ubc1, ubc2, ubc6,
ubc7, ubc8,o rubr1 mutants (data not shown) (21, 50). In
contrast, mutants with temperature-sensitive defects in the
Ubc3 enzyme (Cdc34 [13]) exhibited strong stabilization of
Cln3–b-Gal at the nonpermissive temperature (Fig. 7A). The
stabilization of Cln3–b-Gal observed in cdc34 mutants is at-
tributable to the cdc34 mutations, because Cln3–b-Gal was
stabilized to a higher degree by the stronger of two cdc34
alleles (Fig. 7A) and because transformation of these strains
with a wild-type CDC34 gene completely restored Cln3–b-Gal
instability (data not shown). cdc34 mutants arrest in late G1
upon a temperature shift (13). However, the stabilization of
Cln3–b-Gal does not appear to result from cell cycle redistri-
bution, since stabilization was observed after 30 min at 378C,
whereas the doubling time of wild-type cells was greater than 4
h under these conditions.
The redundant pair of Ubc enzymes Ubc4 and Ubc5 (42),
which are involved in degradation of a variety of short-lived
and abnormal proteins but have not been implicated in cell
cycle regulation, were also required for efﬁcient Cln3–b-Gal
degradation (Fig. 7B). Ubc3 and Ubc4/Ubc5 may therefore
cooperate in the breakdown of Cln3–b-Gal. Experiments to
determine whether degradation of native Cln3 is inhibited in
ubc4 ubc5 double mutants have been hindered by difﬁculties in
pulse-labeling Cln3 in these severely growth defective strains.
Cln3 phosphorylation and degradation in cdc34 mutants.
To address the possible role of Cdc34 in degradation of native
Cln3, we expressed full-length, HA-tagged Cln3 (48) from the
CUP1 promoter. When Cln3-HA was pulse-labeled and immu-
noprecipitated with antibody to the HA epitope, ﬁve electro-
phoretic bands were observed (Fig. 8A). These bands are not
seen in samples from congenic control cells not expressing
Cln3-HA (data not shown). Because all ﬁve bands can be
FIG. 6. Phosphorylation levels of Cln3–b-Gal fusion proteins. Proteins were
pulse-labeled with
35S-amino acids for 5 min and, after a 50-min chase incuba-
tion, analyzed by immunoprecipitation as described in the legend to Fig. 4. The
numbers at the top refer to the Cln3-derived residues present in each fusion
protein. The arrow designates phosphorylated forms. Panels A and B are taken
from the same experiments but are derived from autoradiographic overexposures
(A) and underexposures (B). Panel A illustrates that fusion proteins containing
amino acids 419 to 488, 404 to 488, and 404 to 472 of Cln3 are phosphorylated,
whereas panel B illustrates that the relative level of phosphorylation is highest
for the fusion protein containing amino acids 404 to 488 of Cln3.
FIG. 7. Cln3(404-580)–b-Gal degradation proceeds through a speciﬁc ubiq-
uitin-dependent proteolytic pathway. Degradation of Cln3(404-580)–b-Gal was
measured by pulse-chase analysis in congenic sets of strains. (A) Open circles,
cdc34-1; ﬁlled circles, cdc34-2. (B) Filled circles, ubc4 ubc5. (C) Filled circles,
pre1 pre4. Wild-type strains are represented in all three panels by open squares.
(D and E) Pulse-chase analysis of Cln3–b-Gal degradation in strains overex-
pressing either wild-type ubiquitin (D) or the UbK48R,G76A variant (E). ‘‘P-
Cln3-bgal’’ indicates the position of phosphorylated Cln3. (F) Fluorographic
overexposure of lanes comparable to time zero points of panels D and E.
Brackets indicate the position of presumptive ubiquitin (Ub)–Cln3–b-Gal con-
jugates. Experiments were carried out at either 378C (A and C) or 308C (B, D,
E, and F).
FIG. 8. Phosphorylation and degradation of Cln3-HA in cdc34 and cdc28
mutants. All experiments were done at 378C. In panels A and B, cells were
labeled with
35S-amino acids as described in Materials and Methods. (A) Strains
KY130 (wild type [WT]) and KY203 (cdc34). (B) FC12-18 (wild type [WT]) and
FC10-29 (cdc28). (C) Radiolabeling was carried out with
32Pi for 20 min. On the
basis of relative stabilities and electrophoretic mobilities, we suggest that band a
corresponds to p60 described in reference 5 (i.e., full-length Cln3), band b
corresponds to p65, band c corresponds to p68, and the bands marked with
asterisks correspond to p54 and p52, which decay less rapidly and appear to be
partial breakdown products of Cln3 (5). The pooled intensities of bands a to c
remaining after 10 min was 24% for KY130 (wild type), 82% for KY203 (cdc34),
51% for FC12-18 (wild type), and 89% for FC10-29 (cdc28). Standard deviations
were 6, 19, 4, and 11%, respectively. The experiments in panels A and B were
done independently three and four times, respectively. There was a reproducible
difference in Cln3-HA stability between the two wild-type strains (KY130 and
FC12-18), which was correlated with the level of Cln3-HA phosphorylation at the
zero point. We note that in a previous study, the cdc34-2 mutation appeared to
cause no more than twofold stabilization of Cln3 (48). The stronger effect
observed in the present study could be due to the use of different strains.
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 detected by immunoblotting, they appear to represent variant
forms of Cln3-HA rather than coimmunoprecipitating proteins
(data not shown). The pattern of ﬁve bands closely resembles
that reported by Cross and Blake (5), using antibodies to native
Cln3, and is thus unlikely to reﬂect artifactual consequences of
epitope tagging. However, the bands marked by asterisks ap-
pear to be nonfunctional products of partial Cln3-HA break-
down (5). In wild-type cells, bands a, b, and c decay with
exponential kinetics when quantitated as a group (data not
shown). The characteristics of these bands are described below
and in the legend to Fig. 8. Brieﬂy, band a appears to represent
full-length Cln3, and band b appears to represent a Cln3 vari-
ant that is modiﬁed but not phosphorylated, and band c ap-
pears to represent phosphorylated Cln3. Band c could be de-
tected by in vivo
32Pi labeling (Fig. 8C) and was also eliminated
upon phosphatase treatment (data not shown).
Stabilization of Cln3 is clearly observed in cdc34 mutants
shifted to the nonpermissive temperature (Fig. 8A). In addi-
tion,
32Pi labeling showed directly that the level of phosphor-
ylated Cln3 is enhanced in cdc34 mutants at the nonpermissive
temperature (Fig. 8), consistent with previous observations
(48). The enhanced phosphorylation is also reﬂected in an
increase in the level of band c during the chase incubation in
samples labeled with
35S-amino acids (Fig. 8A). Prior to the
chase incubation, no enhancement of band c is apparent in
cdc34 mutants, suggesting that the rate of Cln3 phosphoryla-
tion is not signiﬁcantly affected by the cdc34 mutation. Thus,
the higher levels of phosphorylated Cln3 in this cdc34 strain
are largely due to stabilization of Cln3 or phosphorylated Cln3.
The observation that both Cln3 and Cln3–b-Gal are stabilized
in cdc34 mutants shows that the fusion protein is degraded by
a pathway the same as or similar to that of the native protein.
Ser-468-dependent phosphorylation implicated in Cln3
(404-488)–b-Gal turnover. As described above, the data in Fig.
4 to 8 are consistent with a role of phosphorylation in the
degradation of Cln3–b-Gal. First, terminal deletions in the
degradation signal of Cln(404-488)–b-Gal, which interfere
with its phosphorylation, also inhibit degradation (Fig. 4 and
6). Second, the stabilization of Cln3–b-Gal was accompanied
by accumulation of its phosphorylated form in UbK48R,G76A
overexpressors, cdc34 mutants, ubc4 ubc5 mutants, and pre1
pre4 mutants (Fig. 7E and data not shown). This was also
observed for Cln3-HA in cdc34 mutants (Fig. 8A). The accu-
mulation of phosphorylated Cln3-HA and Cln3–b-Gal upon
inhibition of degradation suggested that the phosphorylated
forms may be intermediates in turnover and that phosphory-
lation may serve to target Cln3 for degradation.
This possibility was tested by introducing amino acid substi-
tutions at candidate phosphorylation sites. The C-terminal
portion of PEST 2, whose role in degradation was indicated by
deletion analysis, contains the only stringent representation in
the tail region of the consensus site for the Ser/Thr kinase
Cdc28 (Ser-Pro-Tyr-Lys [29]). Substitution of this serine with
alanine stabilized Cln3(404-488)–b-Gal approximately ﬁvefold
(Fig. 9A). The S468A substitution also resulted in a four- to
ﬁvefold-decreased abundance of the phosphorylated band
(Fig. 9C) but did not eliminate it (data not shown), indicating
the existence of at least one other phosphorylation site in the
fusion protein. Stabilization of Cln3(404-580)–b-Gal (Fig. 9B)
by the S468A mutation was approximately 1.5-fold, and the
reduction in normalized levels of phosphorylation was approx-
imately 2-fold. Thus, the effects of the S468A substitution on
Cln3(404-580)–b-Gal phosphorylation and degradation are
much less marked than on Cln3(404-488)–b-Gal. This attenu-
ation of the S468A effect might reﬂect the existence of redun-
dant, independently functioning degradation signals in the
Cln3 tail, as suggested by the deletion analyses.
Role of Cdc28 in Cln3 phosphorylation and degradation.
The results presented above led us to test whether Cln3–b-Gal
degradation is dependent on Cdc28 kinase. At the permissive
temperature, Cln3(404-488)–b-Gal was degraded at compara-
ble rates in wild-type and cdc28-4 mutant cells (data not
shown). At the nonpermissive temperature, however, a four-
fold stabilization of Cln3(404-488)–b-Gal was apparent in the
mutant cells (Fig. 10A). Similar results were obtained with
Cln3(404-580)–b-Gal (data not shown). Stabilization did not
FIG. 9. Effect of a Ser-to-Ala substitution at residue 468 on the phosphoryl-
ation and degradation of Cln3–b-Gal derivatives. (A) Degradation of Cln3(404-
488;S468A)–b-Gal (ﬁlled circles) and the wild-type control (open circles) at
308C. Similar results have been obtained in ﬁve independent experiments. (B)
Degradation of Cln3(404-580;S468A)–b-Gal (ﬁlled circles) and wild-type control
(open circles) at 308C. Similar results have been obtained in three independent
experiments. (C) Cln3(404-488)–b-Gal phosphorylation following a 50-min la-
beling with
35S-amino acids at 258C. Equivalent results were obtained at 308C
and with shorter labeling times. The arrow indicates phosphorylated Cln3(404-
488)–b-Gal. WT, wild type.
FIG. 10. Phosphorylation and degradation of Cln3(404-488)–b-Gal are
CDC28 dependent. (A) Degradation of Cln3(404-488)–b-Gal in cdc28-4 (FC10-
29; circles) and the congenic control (FC12-18; squares) strains. Cln3(404-580)–
b-Gal degradation is similarly dependent on CDC28 (data not shown). (B)
cdc28-dependent phosphorylation of Cln3(404-488)–b-Gal. Cells growing expo-
nentially at 258C were shifted to 378C for 2 h before labeling. The doubling time
of FC12-18 at 378C is 5 h. Galactose induction was carried out in the absence of
alternate carbon sources overnight prior to pulse-labeling. Panel B is from a
5-min pulse-labeling with no chase incubation. Evidence that the retarded form
of Cln3(404-488)–b-Gal corresponds to a phosphorylated species is presented in
Fig. 4 and 5. The retarded form of Cln3(404-488)–b-Gal that is seen in samples
from cells grown at 378C is phosphatase sensitive (data not shown). However, the
extent of electrophoretic retardation produced by phosphorylation was repro-
ducibly greater at 308C than at 378C (in wild-type [WT] cells).
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 result from general inhibition of the ubiquitin pathway, since
there was no stabilization of other ubiquitin-dependent sub-
strates such as ubiquitin–K–b-Gal (data not shown) (50).
As described above, four distinct mutations affecting com-
ponents of the ubiquitin-dependent proteolytic pathway
caused both stabilization of Cln3–b-Gal and accumulation of
its phosphorylated form. In striking contrast, stabilization of
Cln3(404-488)–b-Gal in cdc28 mutants at the nonpermissive
temperature was accompanied by strongly decreased phos-
phorylation (Fig. 10B). This result indicates that Cln3(404-
488)–b-Gal phosphorylation is CDC28 dependent and is in
agreement with point mutant analysis in suggesting a role for
CDC28-dependent phosphorylation of Cln(404-488)–b-Gal in
its degradation. Interestingly, these data also separate a deter-
minant of CDC28-dependent Cln3 degradation from its cyclin
box sequence (Fig. 4), which is thought to be required for
Cdc28 binding and is absent from the Cln3–b-Gal fusions.
The relevance of the results presented above to native Cln3
was addressed by expressing Cln3-HA in cdc28 mutants. After
pulse-labeling with
35S-amino acids at the nonpermissive tem-
perature, the phosphorylated form of Cln3 described above,
represented by band c, was undetectable (Fig. 8B). Cdc28
kinase activity is therefore required for Cln3 phosphorylation
in vivo. Only band a was present at signiﬁcant levels in cdc28
mutants. This band is likely to correspond to p60 described in
reference 5, because both bands accumulate in cdc28 mutants
and both occupy the same position in the electrophoretic lad-
der of Cln3 bands. p60 comigrates with full-length Cln3 (5).
Thus, Cln3 accumulates in an unmodiﬁed form in cdc28 mu-
tants. After 10 min, approximately 50% of Cln3-HA was de-
graded in the wild-type strain, as opposed to 10% in cdc28
mutants, indicating that the cdc28 mutation leads to stabiliza-
tion of Cln3 itself, similarly to Cln3–b-Gal. One interpretation
of these data is that stabilization of Cln3 results from its failure
to be phosphorylated.
DISCUSSION
Progress through the cell cycle is governed by an orderly
succession of cyclin proteins. Accordingly, all known cyclins are
rapidly degraded, either constitutively or in a temporally reg-
ulated fashion. Mitotic cyclin degradation is mediated by a
short sequence known as the destruction box (12). The pro-
teolytic machinery that acts upon mitotic cyclins is abruptly
activated during speciﬁc phases of mitosis (12, 39) and remains
active until the late G1 phase of the subsequent cell cycle (1).
Temporal regulation of mitotic cyclin degradation may be ef-
fected by p34
Cdc28/cdc2-dependent phosphorylation and activa-
tion of a ubiquitin-cyclin ligase (17). In addition, the depen-
dence of cyclin A and B2 degradation on p34
Cdc28/cdc2 may
reﬂect a requirement for the proteolytic substrate to be bound
to p34
Cdc28/cdc2 (44, 49). There is no evidence to suggest that
mitotic cyclin degradation involves Cdc28-dependent phos-
phorylation of cyclins themselves, nor do PEST elements ap-
pear to be involved in mitotic cyclin turnover. In these respects,
and in its CDC34 dependence, the mechanism and regulation
of Cln3 cyclin degradation differ signiﬁcantly from those of
mitotic cyclins.
Cdc34 mediates degradation of Cln3. We have shown that
Cln3 degradation is CDC34 dependent and that phosphoryl-
ated forms of Cln3 accumulate in cdc34 mutants largely as a
consequence of Cln3 stabilization. Two other substrates of the
Cdc34 (Ubc3) pathway have recently been identiﬁed, the tran-
scription factor Gcn4 (24) and the Cdc28 kinase inhibitor Sic1
(41). The inability of cdc34 mutants to degrade Sic1 appears to
account for their conditional lethality and inability to enter S
phase (41). Thus, although initially identiﬁed by virtue of its
requirement for the G1-to-S transition, Cdc34 now appears to
mediate degradation of a variety of proteins, not all of which
are involved in cell cycle control. All three presumptive sub-
strates of Cdc34 contain PEST sequences and are phospho-
proteins (24, 28, 32). On the basis of the results with Cln3, it is
possible that phosphorylation-dependent degradation is a
common feature of Cdc34 substrates.
A degradation signal in Cln3. The tail region of Cln3 func-
tions as a degradation signal in that it is both necessary and
sufﬁcient for the CDC28-dependent, CDC34-dependent deg-
radation characteristic of Cln3 itself. Within the tail region,
many segments contribute to instability, as deﬁned by deletion
analysis of either Cln3 or Cln3–b-Gal fusion proteins. The
results of these two deletion analyses are qualitatively congru-
ent and thus consistent with the view that the proteolytic path-
way for degradation of Cln3–b-Gal fusions reﬂects that of
native Cln3.
The tail (or at least residues 404 to 488 of Cln3) is not a fully
autonomous degradation signal, as Cln3–b-Gal turnover re-
quires the presence of either Lys-15 or Lys-17 of the b-Gal
component of the fusion protein. On the basis of observations
with other b-Gal fusion proteins (50), these residues may pro-
vide ubiquitination sites in Cln3–b-Gal. Thus, the CDC34 and
CDC28 dependence of Cln3 degradation does not appear to be
dependent on the nature of its ubiquitination sites. Cln3 is the
ﬁrst example of a naturally unstable protein whose degradation
signal can function with heterologous ubiquitination sites.
Evidence that the Cln3 degradation signal is activated by
CDC28-dependent phosphorylation. The degradation of a
number of eukaryotic proteins appears to be activated by their
phosphorylation (24, 26). Four lines of evidence suggest that
the Cln3 degradation signal is recognized by the ubiquitination
machinery only in its phosphorylated state. First, deletion stud-
ies indicate that the ability of fragments of the Cln3 tail to
signal degradation of b-Gal is correlated with their phosphor-
ylation (Fig. 4 and 6). Second, mutations affecting ubiquitin or
Ubc enzymes, which inhibit degradation of Cln3 or Cln3–b-
Gal, result in accumulation of phosphorylated forms of these
proteins (Fig. 7 and 8A). Third, an amino acid substitution
within a Cln3 sequence matching the Cdc28 kinase consensus
site results in marked inhibition of both the phosphorylation
and degradation of Cln3(404-488)–b-Gal (Fig. 9). Fourth, in-
activation of Cdc28 kinase inhibits both degradation and phos-
phorylation of Cln3 as well as Cln3–b-Gal derivatives (Fig. 8
and 10). Although the evidence for a role of phosphorylation in
degradation is more extensive for the Cln3–b-Gal fusions than
for Cln3 itself, other data indicate that degradation of the two
proteins proceeds through the same or a similar CDC28-de-
pendent pathway.
The simplest model accounting for the CDC28 dependence
of Cln3 phosphorylation is that Cln3 is phosphorylated by the
same Cdc28 protein that it activates through heterodimer for-
mation. However, our data resolve a major determinant of
CDC28 dependence of Cln3 degradation from the cyclin box,
which is thought to be required for Cdc28 binding and activa-
tion by cyclins. This ﬁnding suggests that Cdc28 kinase is ca-
pable of promoting the phosphorylation of Cln3 proteins other
than (or perhaps in addition to) that by which it is activated.
Such mechanisms could entail either direct phosphorylation of
Cln3 by Cdc28 or indirect pathways involving other protein
kinases. However, it appears that Cln3 can be directly phos-
phorylated by Cdc28 in vitro (48).
Role of PEST elements in the phosphorylation and degra-
dation of Cln3. We have assessed the contribution of PEST
elements to the degradation of both Cln3–b-Gal and Cln3
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 itself. In particular, complementary deletion analyses point to
the PEST 2 element as being important for Cln3 turnover (Fig.
1, 2, and 4). This is the ﬁrst example of a PEST region impli-
cated in targeting a protein for ubiquitin-dependent degrada-
tion. However, we still do not know which features of these
elements are important. It should also be noted that PEST
elements are not necessary for degradation in all unstable
proteins in which they are found and may have other functions.
Interestingly, the consensus recognition sites of Cdc28 kinase,
mitogen-activated protein (MAP) kinase, and casein kinase
(22, 29, 34) are all rich in PEST residues. Thus, PEST elements
might function more generally as targets for phosphorylation
than for degradation. Where involved in degradation, PEST
sequences may serve typically to confer phosphorylation de-
pendence on degradation, as appears to be the case for Cln3–
b-Gal. C-terminal PEST sequences are present in the other G1
cyclins of S. cerevisiae, Cln1 and Cln2 (14), as well as the
mammalian G1 cyclins C, D, and E (25). Thus, PEST se-
quences may play a general role in the degradation of G1
cyclins, perhaps as targets for CDC28-dependent phosphory-
lation.
Cln3 instability and the control of Start. Mitotic cyclins
accumulate over the S and G2 phases in a stable form, and are
abruptly degraded after their time of action, to allow continued
progression of the cell cycle (12, 39). The role of instability in
Cln3 function is likely to be very different. Cln3 does not
appear to be stable prior to its time of action, nor does pre-
cipitous elimination of Cln3 protein occur during normal cell
cycles (47). Instead, Cln3 degradation appears to be important
for timing of the onset of Cln3-dependent processes such as
Start. This view is consistent with the correlation between Cln3
degradation rate and cell size (Fig. 1 to 3).
The instability of Cln3 may allow its levels to reﬂect sensi-
tively the immediate rate of protein synthesis in the cell, which
appears to be important for the execution of Start. This model
suggests that Cln3 levels should be regulated not in a temporal
fashion but as a function of growth conditions. For example, at
low growth rates, phosphorylation of Cln3 may be inhibited,
resulting in stabilization and accumulation of Cln3 to the level
critical for commitment to cell division. Control over Cln3
levels may be achieved through coupling degradation to phos-
phorylation. In particular, the dependence of Cln3 turnover on
Cdc28 kinase provides a mechanism by which cell cycle regu-
lators such as Cln1 and Cln2 could affect Cln3 stability. Inhib-
itors of Cdc28, such as Far1 (27, 46) and Sic1 (28, 32), are also
interesting candidates for such regulation.
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